Puma Biotechnology Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
38.02 M |
Public Float |
28.39 M |
Puma Biotechnology Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$2.61 |
Market Cap |
$471.84 M |
Shares Outstanding |
38.61 M |
Public Float |
32.6 M |
Address |
10880 Wilshire Boulevard Los Angeles California 90024 United States |
Employees | - |
Website | http://www.pumabiotechnology.com |
Updated | 07/08/2019 |
Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. |